In China, Dong et al.26) compared the therapeutic effect of intramuscular administration of G-CSF-mobilized CD34+ cells with G-CSF-mobilized MNCs in 50 patients with CLI caused by TAO (47 patients) and other angiitises (three patients). The gene discussed is CSF3; the disease is thromboangiitis obliterans.